Multiple Myeloma Coverage from Every Angle
Advertisement
Advertisement

Natalie S. Callander, MD, on Relapsed/Refractory Multiple Myeloma: Expert Perspective on New Research

Posted: Tuesday, August 15, 2017

Natalie S. Callander, MD, of the University of Wisconsin Carbone Cancer Center, discusses two studies that are representative of efforts being made in treating relapsed/refractory disease.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.